G

GKB Ophthalmics Ltd
BSE:533212

Watchlist Manager
GKB Ophthalmics Ltd
BSE:533212
Watchlist
Price: 51.99 INR 1.38%
Market Cap: 262m INR

Relative Value

533212 doesn't have a meaningful market cap.

The Relative Value of one GKB stock under the Base Case scenario is 282.01 INR. Compared to the current market price of 51.99 INR, GKB Ophthalmics Ltd is Undervalued by 82%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GKB Relative Value
Base Case
282.01 INR
Undervaluation 82%
Relative Value
Price
G
Worst Case
Base Case
Best Case

Multiples Across Competitors

GKB Competitors Multiples
GKB Ophthalmics Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
GKB Ophthalmics Ltd
BSE:533212
258.5m INR 0.2 -3.4 -11.5 -5.7
JP
Hoya Corp
TSE:7741
8.6T JPY 9.7 41.2 25.5 30.6
CH
Alcon AG
SIX:ALC
31.6B CHF 3.8 36.6 19.1 37.2
US
Medline Inc
NASDAQ:MDLN
35.8B USD 0 0 0 0
DK
Coloplast A/S
CSE:COLO B
130.1B DKK 4.5 34.5 15.8 18.9
US
Align Technology Inc
NASDAQ:ALGN
12.4B USD 3.1 32.6 14.8 18.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
45.6B CNY 10 27.6 25.1 25.1
UK
ConvaTec Group PLC
LSE:CTEC
4.8B GBP 0 0.3 0 0
CA
Bausch + Lomb Corp
NYSE:BLCO
6.1B USD 1.2 -19.9 19.7 92.9
CH
Ypsomed Holding AG
SIX:YPSN
4.6B CHF 5.7 23 15 20.3
JP
Asahi Intecc Co Ltd
TSE:7747
790.7B JPY 6.3 52.2 22.9 33.3
P/E Multiple
Earnings Growth PEG
IN
G
GKB Ophthalmics Ltd
BSE:533212
Average P/E: 31
Negative Multiple: -3.4
N/A N/A
JP
Hoya Corp
TSE:7741
41.2
13%
3.2
CH
Alcon AG
SIX:ALC
36.6
25%
1.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
34.5
22%
1.6
US
Align Technology Inc
NASDAQ:ALGN
32.6
27%
1.2
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
27.6
10%
2.8
UK
ConvaTec Group PLC
LSE:CTEC
0.3
33%
0
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -19.9 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
23
34%
0.7
JP
A
Asahi Intecc Co Ltd
TSE:7747
52.2
35%
1.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
G
GKB Ophthalmics Ltd
BSE:533212
Average EV/EBITDA: 17.6
Negative Multiple: -11.5
N/A N/A
JP
Hoya Corp
TSE:7741
25.5
11%
2.3
CH
Alcon AG
SIX:ALC
19.1
8%
2.4
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
15.8
8%
2
US
Align Technology Inc
NASDAQ:ALGN
14.8
13%
1.1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
25.1
15%
1.7
UK
ConvaTec Group PLC
LSE:CTEC
0
10%
0
CA
Bausch + Lomb Corp
NYSE:BLCO
19.7
21%
0.9
CH
Ypsomed Holding AG
SIX:YPSN
15
21%
0.7
JP
A
Asahi Intecc Co Ltd
TSE:7747
22.9
10%
2.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
G
GKB Ophthalmics Ltd
BSE:533212
Average EV/EBIT: 30.8
Negative Multiple: -5.7
N/A N/A
JP
Hoya Corp
TSE:7741
30.6
N/A N/A
CH
Alcon AG
SIX:ALC
37.2
23%
1.6
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
18.9
8%
2.4
US
Align Technology Inc
NASDAQ:ALGN
18.8
15%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
25.1
11%
2.3
UK
ConvaTec Group PLC
LSE:CTEC
0
22%
0
CA
Bausch + Lomb Corp
NYSE:BLCO
92.9
60%
1.5
CH
Ypsomed Holding AG
SIX:YPSN
20.3
29%
0.7
JP
A
Asahi Intecc Co Ltd
TSE:7747
33.3
N/A N/A